Status:
RECRUITING
Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma
Lead Sponsor:
Costantino Errani
Conditions:
Bone Metastases
Eligibility:
All Genders
18+ years
Brief Summary
From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022. A review will be made from the medical records, radiological ima...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
- Availability of imaging and clinical data
- Availability of at least one follow-up during the last 12 months form diagnosis
Exclusion
- At least one inclusion creteria not met
Key Trial Info
Start Date :
September 23 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06524843
Start Date
September 23 2024
End Date
December 1 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, Italy, 40134